Clinical efficacy evaluation of taVNS for patients with IBS-D

Wangjing Hospital, Chinese Academy of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•To be admitted to the study, patients must meet all six of the following criteria:
•(1) The case met the above western diagnostic criteria;
•(2) Blood routine, urine routine, stool routine plus occult blood, biochemical and imaging tests to exclude other serious chronic diseases;
•(3) male and female patients aged 18 to 65 years;
•(4) Course of disease > 6 months;
•(5) No drug treatment was given within 4 weeks before enrollment;
•(6) Patients and their family members shall be informed and sign informed consent.

•Patients meeting 1 or more of the following criteria should be excluded:
•(1) patients with severe liver and kidney function injury, severe heart, brain and lung diseases and severe mental diseases;
•(2) patients aged under 18 years or over 65 years;
•(3) during the observation period, taking other drugs, such as opioid antidiarrheal drugs or selective 5-HT reuptake inhibitors, affected the observation results;
•(4) Subjects are unwilling to participate in the test or have poor compliance;
•(5) pregnant or lactating women;
•(6) Patients with other body surface electrical stimulation or acupuncture therapy involved in the original treatment plan.
•(7) Patients with ear ulceration and other skin lesions.
•(8) Patients with known hypersensitivity to trimebutin maleate.

发起方

Wangjing Hospital, Chinese Academy of Traditional Chinese Medicine